Green Lifescience Co., Ltd.

KOSDAQ:A114450 Stock Report

Market Cap: ₩41.0b

Green Lifescience Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Green Lifescience.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Life Sciences earnings growth23.5%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Analysis Article May 27

Green Lifescience's (KOSDAQ:114450) Earnings Are Weaker Than They Seem

Investors were disappointed with Green Lifescience Co., Ltd.'s ( KOSDAQ:114450 ) earnings, despite the strong profit...
Analysis Article Dec 25

Lacklustre Performance Is Driving Green Lifescience Co., Ltd.'s (KOSDAQ:114450) 26% Price Drop

Green Lifescience Co., Ltd. ( KOSDAQ:114450 ) shares have retraced a considerable 26% in the last month, reversing a...
Analysis Article Oct 31

There Is A Reason Green Lifescience Co., Ltd.'s (KOSDAQ:114450) Price Is Undemanding

Green Lifescience Co., Ltd.'s ( KOSDAQ:114450 ) price-to-sales (or "P/S") ratio of 2.2x might make it look like a buy...
Analysis Article Aug 18

Is Green Lifescience (KOSDAQ:114450) Weighed On By Its Debt Load?

KOSDAQ:A114450 1 Year Share Price vs Fair Value Explore Green Lifescience's Fair Values from the Community and select...
Analysis Article Jul 11

Revenues Working Against Green Lifescience Co., Ltd.'s (KOSDAQ:114450) Share Price Following 34% Dive

The Green Lifescience Co., Ltd. ( KOSDAQ:114450 ) share price has softened a substantial 34% over the previous 30 days...
Analysis Article Jun 25

Estimating The Intrinsic Value Of Green Lifescience Co., Ltd. (KOSDAQ:114450)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Green Lifescience fair value estimate is ₩3,081 With ₩3,185...
Analysis Article May 21

Improved Revenues Required Before Green Lifescience Co., Ltd. (KOSDAQ:114450) Stock's 38% Jump Looks Justified

Green Lifescience Co., Ltd. ( KOSDAQ:114450 ) shareholders would be excited to see that the share price has had a great...
Analysis Article Mar 06

Is Green Lifescience (KOSDAQ:114450) A Risky Investment?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article Dec 09

Why Investors Shouldn't Be Surprised By Green Lifescience Co., Ltd.'s (KOSDAQ:114450) 27% Share Price Plunge

Green Lifescience Co., Ltd. ( KOSDAQ:114450 ) shareholders that were waiting for something to happen have been dealt a...
Analysis Article Nov 13

Is Green Lifescience (KOSDAQ:114450) Using Debt In A Risky Way?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article Sep 13

Green Lifescience Co., Ltd.'s (KOSDAQ:114450) 36% Dip In Price Shows Sentiment Is Matching Revenues

The Green Lifescience Co., Ltd. ( KOSDAQ:114450 ) share price has softened a substantial 36% over the previous 30 days...
Analysis Article Jul 30

The Market Doesn't Like What It Sees From Green Lifescience Co., Ltd.'s (KOSDAQ:114450) Revenues Yet

You may think that with a price-to-sales (or "P/S") ratio of 1.7x Green Lifescience Co., Ltd. ( KOSDAQ:114450 ) is...
Analysis Article Mar 26

Health Check: How Prudently Does Green Lifescience (KOSDAQ:114450) Use Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Feb 22

KPX Lifescience.Co.Ltd (KOSDAQ:114450) Has Debt But No Earnings; Should You Worry?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article Dec 31

Investors Who Bought KPX Lifescience.Co.Ltd (KOSDAQ:114450) Shares Three Years Ago Are Now Up 180%

KPX Lifescience.Co.,Ltd. ( KOSDAQ:114450 ) shareholders might be concerned after seeing the share price drop 26% in the...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Green Lifescience has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A114450 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202651,0173,011-3,439-1,939N/A
12/31/202540,340110-796364N/A
9/30/202534,656-366-1,844-1,134N/A
6/30/202527,756-1,953-3,479-2,678N/A
3/31/202523,191-6424551,366N/A
12/31/202424,8611,562-315525N/A
9/30/202421,587-12,6642,1633,143N/A
6/30/202424,604-12,0404061,121N/A
3/31/202424,993-14,416-1,061-563N/A
12/31/202322,369-16,358-136370N/A
9/30/202323,129-5,177-1,762-1,491N/A
6/30/202322,314-5,058-4,434-3,797N/A
3/31/202325,900-4,513-1,154-216N/A
12/31/202236,505-3,526-6,030-4,552N/A
9/30/202239,978-2,267-4,405-1,192N/A
6/30/202239,758-2,696-2,3641,055N/A
3/31/202234,441-2,524-6,191-2,831N/A
12/31/202125,338-3,136-2,832611N/A
9/30/202122,361-2,615-3,314-866N/A
6/30/202121,203-1,928-4,452-2,198N/A
3/31/202124,440-854-1,1871,590N/A
12/31/202024,561-1,059-7651,902N/A
9/30/202028,036-8-1,2261,897N/A
6/30/202031,8754281,1535,036N/A
3/31/202033,657140-9432,021N/A
12/31/201937,6181,196N/A4,242N/A
9/30/201934,305-601N/A3,463N/A
6/30/201934,030-815N/A3,597N/A
3/31/201931,294-1,551N/A5,377N/A
12/31/201832,754-1,445N/A5,377N/A
9/30/201836,947-607N/A4,497N/A
6/30/201839,978433N/A2,812N/A
3/31/201842,115953N/A3,865N/A
12/31/201742,5852,225N/A5,681N/A
9/30/201741,6654,081N/A5,812N/A
6/30/201743,5154,408N/A8,779N/A
3/31/201746,1175,239N/A8,558N/A
12/31/201643,3044,504N/A7,067N/A
9/30/201646,7405,882N/A8,284N/A
6/30/201646,1535,667N/A7,760N/A
3/31/201646,2195,661N/A8,400N/A
12/31/201545,5085,387N/A5,617N/A
9/30/201543,5932,262N/A6,111N/A
6/30/201542,1411,075N/A3,476N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A114450's forecast earnings growth is above the savings rate (3.1%).

Earnings vs Market: Insufficient data to determine if A114450's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A114450's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A114450's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A114450's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if A114450's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/12 17:13
End of Day Share Price 2026/06/12 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Green Lifescience Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.